Bioelectronics Corp (BIEL)

[Zorax]

Not sure what you're talking about but cleared for OTC sales in the U.S. Means they can be sold in the U.S.

Last time to debunk this, biel got the actipatch reclassified from a class III to a class II mostly because they got caught with false claims of the product with no 3rd party testing at the time.
Getting a reclassification is not a APPROVAL by the FDA to sell anything. biel did not process further than that.

And the comment about shelf space is nonsense.

All this is moot when the lawsuit hammer comes down very soon anyways.